Methadone Hydrochloride Market, by Formulation (Tablet, Solution, and Others), by Application (Opiate Withdrawal, Chronic Pain, and Others), by Route of Administration (Oral and Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies

Methadone Hydrochloride Market, by Formulation (Tablet, Solution, and Others), by Application (Opiate Withdrawal, Chronic Pain, and Others), by Route of Administration (Oral and Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Methadone, a synthetic narcotic analgesic is part of a category called opioids. This opioid has pharmacologic actions qualitatively similar to morphine. Methadone is generally used as a pain reliever and as a part of drug addiction detoxification and maintenance therapy. Pain can be of various types such as due to surgery, strain, and others. A person experiencing severe and chronic pain is given small doses of methadone, which encounters the pain by changing the way the brain and nervous system respond to pain. Opiate dependence is a major public health problem.
Market Dynamics
Key players are focusing on mergers and acquisitions to strengthen their position in the global methadone hydrochloride market. For instance, in May 2016, Hikma Pharmaceuticals PLC acquired Roxane Laboratories, Inc., a pharmaceutical company. Through this acquisition, the company expanded its product portfolio of opiate agonist by acquiring methadone hydrochloride from Roxane Laboratories, Inc
Key features of the study:
This report studies the current scenario as well as the future market potential of methadone hydrochloride across the globe. The market for methadone hydrochloride has been segmented on the basis of formulation, application, route of administration, distribution channel, and region.
This report provides in-depth analysis of the global methadone hydrochloride market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, regional outlook, and competitive strategies adopted by the leading players.
It profiles leading players in the global methadone hydrochloride market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future market expansion and marketing tactics
Key companies covered as a part of this study are Eli Lilly and Company, Sanofi S.A, Hikma Pharmaceuticals PLC, Mallinckrodt Pharmaceuticals, Siegfried Holding AG, Johnson Matthey, Tianjin Central Pharmaceutical Co., Ltd, Temad Co, Embio LTD, Harman Finochem Ltd, and Rusan Pharma Ltd.
The global methadone hydrochloride market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
Stakeholders would greatly benefit in decision-making through various strategy matrices used in analyzing the global methadone hydrochloride market
Detailed Segmentation:
Global Methadone Hydrochloride Market, By Formulation :
Tablet
Solution
Others
Global Methadone Hydrochloride Market, By Application:
Opiate Withdrawal
Chronic Pain
Others
Global Methadone Hydrochloride Market, By Route of Administration :
Oral
Intravenous
Global Methadone Hydrochloride Market, By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Methadone Hydrochloride Market, By Region:
North America
By Formulation :
Tablet
Solution
Others
By Application:
Opiate Withdrawal
Chronic Pain
Others
By Route of Administration:
Oral
Intravenous
By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Formulation :
Tablet
Solution
Others
By Application:
Opiate Withdrawal
Chronic Pain
Others
By Route of Administration:
Oral
Intravenous
By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Formulation :
Tablet
Solution
Others
By Application:
Opiate Withdrawal
Chronic Pain
Others
By Route of Administration:
Oral
Intravenous
By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Formulation :
Tablet
Solution
Others
By Application:
Opiate Withdrawal
Chronic Pain
Others
By Route of Administration:
Oral
Intravenous
By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Formulation :
Tablet
Solution
Others
By Application:
Opiate Withdrawal
Chronic Pain
Others
By Route of Administration:
Oral
Intravenous
By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
GCC
Israel
Rest of Middle East
Africa
By Formulation :
Tablet
Solution
Others
By Application:
Opiate Withdrawal
Chronic Pain
Others
By Route of Administration:
Oral
Intravenous
By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Eli Lilly and Company *
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
Sanofi S.A
Hikma Pharmaceuticals PLC
Mallinckrodt Pharmaceuticals
Siegfried Holding AG
Johnson Matthey
Tianjin Central Pharmaceutical Co., Ltd
Temad Co
Embio LTD
Harman Finochem Ltd
Rusan Pharma Ltd
“*” marked represents similar segmentation in other categories in the respective section.